---
title: "Singapore Institute of Advanced Medicine Wins SGX Nod for Major Rights and Warrants Issue"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286124513.md"
description: "Singapore Institute of Advanced Medicine Holdings Ltd. has received approval from the Singapore Exchange for a renounceable non-underwritten rights cum warrants issue. The offer includes up to 492.6 million new shares at S$0.031 each and an equal number of free detachable warrants exercisable at S$0.050. This fundraising structure allows existing shareholders to participate in capital raising, with further announcements expected as the transaction progresses. The company operates in advanced medical diagnostics and treatment services and is listed on the Catalist board of the Singapore Exchange."
datetime: "2026-05-12T15:12:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286124513.md)
  - [en](https://longbridge.com/en/news/286124513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286124513.md)
---

# Singapore Institute of Advanced Medicine Wins SGX Nod for Major Rights and Warrants Issue

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Singapore Institute of Advanced Medicine Holdings Ltd. ( (SG:9G2) ) just unveiled an announcement.

Singapore Institute of Advanced Medicine Holdings has received approval in principle from the Singapore Exchange for a renounceable non-underwritten rights cum warrants issue on the Catalist board. The offer will comprise up to 492.6 million new shares at S$0.031 each and an equal number of free detachable warrants exercisable at S$0.050, subject to compliance with listing requirements and ensuring sufficient warrant spread.

The fundraising structure, which offers two rights shares and two free warrants for every five existing shares, is intended to provide existing shareholders with an opportunity to participate in the company’s capital raising while potentially enhancing future capital inflows through warrant exercises. The company plans to lodge an offer information statement in due course and has indicated that further announcements will follow as the transaction progresses through regulatory and market steps.

**More about Singapore Institute of Advanced Medicine Holdings Ltd.**

Singapore Institute of Advanced Medicine Holdings Ltd. operates in the healthcare sector, focusing on advanced medical diagnostics and treatment services through its group of subsidiaries in Singapore. The company is listed on the Catalist board of the Singapore Exchange, positioning it within the growth-oriented segment of the local capital market.

**Average Trading Volume:** 4,003,158

**Technical Sentiment Signal:** Buy

**Current Market Cap:** S$59.11M

### Related Stocks

- [9G2.SG](https://longbridge.com/en/quote/9G2.SG.md)

## Related News & Research

- [Abaxx to Launch Silver Singapore Futures on May 22, 2026 | ABXXF Stock News](https://longbridge.com/en/news/286762247.md)
- [Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger](https://longbridge.com/en/news/286877547.md)
- [Morgans Reaffirms Their Buy Rating on Shape Australia Corporation Limited (SHA)](https://longbridge.com/en/news/286714508.md)
- [Ever Glory United’s order book hits over $900m after new $230m contracts](https://longbridge.com/en/news/286849867.md)
- [Release according to article 135 section 2 BörseG](https://longbridge.com/en/news/286754366.md)